Back to all studies
Not Yet RecruitingNCT06765824

Transcranial Magnetic Stimulation in people with Dual Disorders

This study is not yet recruiting. It focuses on depression and currently lists study information in Spain.

Depression, Tobacco AddictionDeviceFrom 18 Years to 65 Years
Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT06765824. We help you review the study, but cannot decide medical eligibility.
In plain English

Key information made simple

This study is comparing Repetitive Transcranial Magnetic Stimulation with Transcranial Magnetic Stimulation-Sham coil for people with Major Depression or Tobacco Addiction. Participants receive Repetitive Transcranial Magnetic Stimulation or Transcranial Magnetic Stimulation-Sham coil and complete study visits and assessments. Some participants may receive Transcranial Magnetic Stimulation-Sham coil instead of the study treatment, and direct benefit is not guaranteed.

What to expect

Your next step

The official record suggests in-person participation through a hospital, with sites including Consorcio Hospitalario Provincial de Castellón. Participation appears to involve assessments along with scans or samples to help researchers understand patterns more clearly. The main fit is usually being able to understand the study and consent and having a stable enough treatment background for the study, while common reasons not to take part include pregnancy or breastfeeding and other factors that could make participation unsuitable. This is a later-stage study, which usually means a larger group and a closer look at how well the approach holds up.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateEstimated: February 2025
Recruitment status
Not Yet Recruiting
Estimated enrollment
Not clearly listed
Sponsor
Cardenal Herrera University
Sponsor type
University
Study type
Device
Intervention type
Device / app / digital / technology
Study phase
Not clearly listed
Locations
Spain
Age range
From 18 Years to 65 Years
Official registry ID
NCT06765824
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT06765824. We help you review the study, but cannot decide medical eligibility.
Why this study may matter

Why this study may matter

This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.

In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in Spain.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medical device for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. It includes a comparison with a sham comparison. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a device, app, or technology?

This appears to be a device / app / digital / technology study. The phase is not clearly listed in the public registry. Phase is mostly relevant for medication studies and some device studies. For this study, it may be more useful to look at what is required, the duration, visits, and eligibility criteria.

Do I need to want to stop or reduce tobacco use to participate?

The public registry appears to mention tobacco, nicotine, alcohol, cannabis, or another addiction-related topic. Ask the study team whether you need to want to stop, reduce, already be abstinent, or simply meet use-related criteria. Eligibility must be confirmed by the study team.

What would I likely need to do?

You may need to use a device, app, or digital tool for a defined period. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What should I check about data, monitoring, alerts, and daily use?

If the study uses a device, app, or digital tool, check what data is collected, who can access it, how often you need to use it, and what happens if the tool detects a concerning signal. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Cardenal Herrera University, which appears to be a university. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The registry indicates that this study has not started recruiting yet. You can check the planned start date and available contacts.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Transcranial Magnetic Stimulation in people with Dual Disorders — Depression Clinical Trial | HopeStage